Covered recipient · General Payments record
JOHN D CHANDLER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2024–2025
$269.84
- Reported across 16 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $233.84 | 14 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $87.88 | 5 |
| E.R. Squibb & Sons, L.L.C. | $49.92 | 3 |
| Merck Sharp & Dohme Corporation | $20.06 | 1 |
| ABBVIE INC. | $18.21 | 1 |
| Novo Nordisk AS | $16.08 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.51 | 1 |
| Exact Sciences Corporation | $13.70 | 1 |
| PFIZER INC. | $13.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (14)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.21 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201629650 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.51 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222937600 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.02 | 04/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184387405 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.67 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184387413 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.23 | 07/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184387421 | CMS |
| Exact Sciences Corporation | $13.70 | 05/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235283640 | CMS |
| Lilly USA, LLC | $15.19 | 01/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186709857 | CMS |
| Lilly USA, LLC | $14.29 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186736203 | CMS |
| Lilly USA, LLC | $19.12 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186722743 | CMS |
| Lilly USA, LLC | $19.85 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186657011 | CMS |
| Lilly USA, LLC | $19.43 | 09/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186676829 | CMS |
| Merck Sharp & Dohme LLC | $20.06 | 07/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238300227 | CMS |
| Novo Nordisk Inc | $16.08 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188676995 | CMS |
| PFIZER INC. | $13.48 | 09/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229355365 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.